Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Discrete breathers in Klein-Gordon lattices: A deflation-based approach.

Chaos (Woodbury, N.Y.)·2023
Same author

Bifurcation analysis of two-dimensional Rayleigh-Bénard convection using deflation.

Physical review. E·2022
Same author

High efficiency photomodulators for millimeter wave and THz radiation.

Scientific reports·2019
Same author

Are high-risk obstetric patients properly identified and managed?

International journal of obstetric anesthesia·2018
Same author

Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy.

JAMA oncology·2018
Same author

Factors controlling headspace pressure in a manual manometric BMP method can be used to produce a methane output comparable to AMPTS.

Bioresource technology·2017

相关实验视频

Updated: Jul 9, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

修改后的Fontan手术对低可塑性左心综合征的结果和评估.

P E Farrell1, A C Chang, K A Murdison

  • 1Division of Cardiology, Children's Hospital of Philadelphia, PA 19104.

Circulation
|January 11, 1992
PubMed
概括
此摘要是机器生成的。

对于低可塑性左心综合征 (HLHS) 修改后的Fontan手术的生存率与其他复杂的心脏病状况相比较. 作为系统性心室的右心室在HLHS幸存者中显示出优异的中间结果.

更多相关视频

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
06:29

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring

Published on: May 2, 2025

相关实验视频

Last Updated: Jul 9, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
06:29

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring

Published on: May 2, 2025

科学领域:

  • 儿童心脏病学 儿童心脏病学
  • 生产性心脏手术 手术 生产心脏手术
  • 心脏生理学 心脏生理学

背景情况:

  • 该研究回顾了76名患有低可塑性左心综合征 (HLHS) 的患者的结果,这些患者接受了经过修改的Fontan手术.
  • 5个月至6岁的患者在1984年至1989年期间在Fontan手术之前接受了息性手术.

研究的目的:

  • 评估HLHS患者修改后的Fontan手术的结果.
  • 评估使用右心室作为HLHS幸存者的全身心室的中间结果.

主要方法:

  • 经过修改的Fontan手术包括过心脏阻塞 (n=10) 或下静脉空腔阻塞与肺动脉增大 (n=66).
  • 精算生存率计算在1个月,1年,2年和4年.
  • 在幸存者身上进行了术后心脏导管,以评估血液动力学值.

主要成果:

  • 精算生存率为74% (1个月),58% (12个月),56% (2年) 和52% (4年).
  • 在25名穿透导管的幸存者中,血液动力学值显示心脏指数为2.8 +/- 0.6 l/min/m2,右动脉压为11 +/- 2 mm Hg.
  • 没有观察到显著的三管或本源肺 insufficiency.

结论:

  • 对于HLHS,Fontan手术后的存活率与其他复杂的先天性心脏病变相当.
  • 作为系统性心室的右心室在经历了重建和Fontan手术的HLHS患者中产生了出色的中间结果.